Anondita Medicare, the company behind a product designed to make private moments safer, is now drawing plenty of attention on the stock market too. Shares of the firm, which manufactures condoms under the Cobra brand, jumped sharply on Wednesday, 24 June. During the session the stock touched a high of ₹1,260. The biggest trigger behind the surge was a fresh order from South Africa, where the company has bagged an additional international purchase order worth ₹5.11 crore for the supply of condoms. Over the past 10 months, the stock has delivered a bumper return of 740% to its investors.
In Wednesday's trade, Anondita Medicare ended 3.42% higher at ₹1,233.15 on the NSE, taking the company's market capitalisation to ₹2,230 crore. Over the last year, the stock has logged a 52-week high of ₹1,316 and a 52-week low of ₹261.75.
The Journey Since the IPO
Anondita Medicare made its debut on the NSE SME platform on 1 September 2025, and the start was nothing short of explosive. Investors lapped up the IPO, which was subscribed more than 300 times overall. The shares were issued at ₹145 apiece in the IPO. On listing day, the stock opened at ₹275.50 on the NSE SME, handing IPO investors a 90% listing gain on day one itself.
The stock never looked back after that. On 24 June 2026, it climbed all the way to ₹1,233.15. Measured against the IPO price of ₹145, the share has now leapt 740%.
How the Stock Has Performed Recently
Looking at its recent track record, the stock is up 1.51% over the past week and has gained 11.79% in the last month. Over a three-month window, it has delivered a strong return of 78.72%. So far in 2026, the share has risen 21.24%.
The Business and the Bottom Line
Incorporated in March 2024, Anondita Medicare produces flavoured male condoms under the Cobra brand. The company makes 56.2 crore condoms every year, and its manufacturing facility is located in Noida. Beyond India, it exports its products to Southeast Asia, Africa and the Middle East.
On the financial front, the company posted a net profit of ₹35 crore in FY2023, ₹3.84 crore in FY2024 and ₹16.42 crore in FY2025.
